HCAYX
Price
$62.75
Change
-$0.59 (-0.93%)
Updated
Jul 13 closing price
Net Assets
6.29B
VFFSX
Price
$367.80
Change
-$2.94 (-0.79%)
Updated
Jul 13 closing price
Net Assets
1.67T
Interact to see
Advertisement

HCAYX vs VFFSX

HCAYX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
HCAYX vs. VFFSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCAYX is a Buy and VFFSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.67T vs. HCAYX (6.29B). VFFSX pays higher dividends than HCAYX: VFFSX (1.08) vs HCAYX (0.33). HCAYX was incepted earlier than VFFSX: HCAYX (30 years) vs VFFSX (10 years). HCAYX (0.81) is less costly to investors than VFFSX (0.01). HCAYX is a more actively managed with annual turnover of: 94.00 vs. VFFSX (2.00). HCAYX has a lower initial minimum investment than VFFSX: HCAYX (250000) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 21.07 vs. HCAYX (11.48). VFFSX return over 5 years is better than : 73.48 vs. HCAYX (12.68).
HCAYXVFFSXHCAYX / VFFSX
Total Expense Ratio0.810.018,100%
Annual Report Gross Expense Ratio0.810.018,100%
Fund Existence30 years10 years-
Gain YTD9.01910.68584%
Front LoadN/AN/A-
Min. Initial Investment25000050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.29B1.67T0%
Annual Yield % from dividends0.331.0831%
Returns for 1 year11.4821.0754%
Returns for 3 years34.9968.4551%
Returns for 5 years12.6873.4817%
Returns for 10 years67.36251.2127%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZIEX20.58N/A
N/A
Lazard International Equity Instl
CMNWX91.13N/A
N/A
Principal Capital Appreciation A
PRWCX38.43N/A
N/A
T. Rowe Price Capital Appreciation
TRZYX24.28N/A
N/A
T. Rowe Price Latin America Z
MCYSX16.25-0.50
-2.99%
NYLI Candriam Emerging Markets Eq Cl R6